Treatment for increasing the amount of autologous blood: The solution is administered intravenously over approx. 2 minutes or subcutaneously. Recormon is administered twice weekly over 4 weeks. On those occasions where the patient's PCV allows blood donation, i.e. PCV ≥ 33 %, Recormon is administered at the end of blood donation.

2025年1月7日 · Recormon regulates erythropoiesis by stimulating the differentiation and proliferation of erythroid precursors, stimulating the release of reticulocytes into the circulation, and synthesis of cellular haemoglobin.

For use of Recormon in an autologous blood predonation programme, the official guidelines on principles of blood donation must be considered, in particular: only patients with a PCV 33% (hemoglobin 11 g/dl [6.83 mmol/l]) should donate;

【篤實 關懷 倫理 卓越】光田綜合醫院 Kuang Tien General Hospital

2024年8月28日 · Recormon helps to increase red blood cell production in patients with anemia that is related to kidney problems. It is also used for patients with anemia associated to blood cancers.

商品名： 罗可曼Recormon 通用名： 重组人促红素-β注射液（CHO细胞）

【药品名称】 通用名：重组人促红素-β注射液（CHO细胞） 商品名：罗可曼Recormon 【生产企业】 上海罗氏制药有限公司 【成份】 主要组成成份：重组人促红素-β（CHO细胞）

罗可曼（重组人红细胞生成素β注射液），适应症为本品适用于因慢性肾衰竭引致贫血，包括行血液透析、腹膜透析和非透析治疗者。治疗接受化疗的非髓性恶性肿瘤成人患者的症状性贫血。本品用于治疗贫血时，仅在出现贫血症状时方可使用。

RECORMON的用量、作用機轉、副作用、懷孕及哺乳用藥與藥物交互作用，RECORMON適應症:

Treatment for increasing the amount of autologous blood: The reconstituted solution is administered intravenously over approx. 2 minutes or subcutaneously. Recormon is administered twice weekly over 4 weeks. On those occasions where the patient’s PCV allows blood donation, i.e. PCV ≥ 33 %, Recormon is administered at the end of blood donation.